This report - which is available individually or as part of a full subscription to Global PV Tracker - examines the trends and opportunities in patient caseloads and procedure volumes in ear, nose & throat surgery markets.
Ear, nose and throat (ENT) surgery includes a wide range of open and minimally invasive procedures performed on ear, nose and throat structures, organs and glands for indications including infection, cancer, trauma, sinusitis, obstructive sleep apnea and other conditions affecting the ear, nose and throat. The primary types of ENT surgery procedures are tonsillectomy, ear procedures (myringoplasty, tympanoplasty), functional endoscopic sinus surgery (FESS), tracheostomy, thyroidectomy and parathyroidectomy, adenoidectomy, tongue operations (glossectomy, frenectomy), laryngeal operations, pharyngeal operations, and radical neck dissection. In 2017, the number of ENT surgery procedures performed worldwide totaled approximately 16 million. The number of procedures per year is forecast to grow at a 5.7% compound annual rate over the 2017-2022 interval, with volume exceeding 21 million by 2022, making ENT surgery one of the fastest growing surgical procedure categories. Among the nine major categories of surgical procedures, ENT surgery ranks third highest after stereotactic radiosurgery and spine surgery.
QUESTIONS ANSWERED IN THIS REPORT:
DATABOOK: Buyers of this report also receive an Excel dashboard containing ear, nose & throat surgery procedure forecasts segmented by global, region (4) and country (32).
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
